Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Synergy of Human Immunodeficiency Virus Protease Inhibitors with Chloroquine against Plasmodium falciparum In Vitro and Plasmodium chabaudi In Vivo

Zhengxiang He, Li Qin, Lili Chen, Nanzheng Peng, Jianlan You, Xiaoping Chen
Zhengxiang He
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510663, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Qin
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510663, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lili Chen
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510663, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nanzheng Peng
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510663, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianlan You
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510663, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoping Chen
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510663, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chen_xiaoping@gibh.ac.cn
DOI: 10.1128/AAC.01329-07
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Isobolograms of the interaction of chloroquine with HIV PIs against chloroquine-resistant clone Dd2 (▪) and chloroquine-sensitive clone 3D7 (▴) in vitro. The effect of the combination of HIV PIs with chloroquine against malaria parasites was tested by titration of the two drugs at fixed ratios proportional to their 50% effective concentrations. The results were expressed as fractional inhibitory concentrations (FICs), and I values were calculated to quantitate the interaction between HIV PIs and chloroquine. The results are means of three independent experiments.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Synergistic suppression of chloroquine resistance of P. chabaudi ASCQ by chloroquine in combination with ritonavir. Mice infected with chloroquine-resistant P. chabaudi ASCQ were treated with the single drug chloroquine (CQ) or ritonavir (R) or a combination of both at specified dosages by oral administration. The results are expressed as means and standard errors (n = 6). ☆☆, P < 0.01 versus the untreated group; ▵, P < 0.05, and ▵▵, P < 0.01 versus single CQ- or R-treated groups.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Synergistic suppression of P. chabaudi ASCQ and ASS by chloroquine in combination with HIV PIs. Mice infected with either the chloroquine-resistant line ASCQ (A) or the chloroquine-sensitive line ASS (B) of P. chabaudi were treated with a single drug (CQ or HIV PIs) or a combination of two drugs at specified dosages by oral administration. The results shown are means and standard errors (n = 6). ☆☆, P < 0.01 versus the untreated group; ▵, P < 0.05, and ▵▵, P < 0.01 versus the single-drug CQ-treated group. CQ, chloroquine; S, saquinavir; L, lopinavir; A, atazanavir; R, ritonavir; N, nelfinavir.

PreviousNext
Back to top
Download PDF
Citation Tools
Synergy of Human Immunodeficiency Virus Protease Inhibitors with Chloroquine against Plasmodium falciparum In Vitro and Plasmodium chabaudi In Vivo
Zhengxiang He, Li Qin, Lili Chen, Nanzheng Peng, Jianlan You, Xiaoping Chen
Antimicrobial Agents and Chemotherapy Jun 2008, 52 (7) 2653-2656; DOI: 10.1128/AAC.01329-07

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Synergy of Human Immunodeficiency Virus Protease Inhibitors with Chloroquine against Plasmodium falciparum In Vitro and Plasmodium chabaudi In Vivo
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Synergy of Human Immunodeficiency Virus Protease Inhibitors with Chloroquine against Plasmodium falciparum In Vitro and Plasmodium chabaudi In Vivo
Zhengxiang He, Li Qin, Lili Chen, Nanzheng Peng, Jianlan You, Xiaoping Chen
Antimicrobial Agents and Chemotherapy Jun 2008, 52 (7) 2653-2656; DOI: 10.1128/AAC.01329-07
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antimalarials
chloroquine
HIV Protease Inhibitors
Plasmodium chabaudi
Plasmodium falciparum

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596